The latest update is out from Windtree Therapeutics (WINT).
Windtree Therapeutics, Inc. has entered into a Securities Purchase Agreement for a private placement of Series C Convertible Preferred Stock and Warrants, aiming to raise approximately $12.9 million. A portion of the funds was obtained by converting existing debt and preferred stock. The company anticipates using the proceeds for general corporate purposes and working capital. The deal includes specific conditions such as seeking shareholder approval for common stock issuance upon conversion or exercise of the warrants, and restrictions on equity or equity-linked securities issuance during a set period following the deal.
Learn more about WINT stock on TipRanks’ Stock Analysis page.
